Post-traumatic endophthalmitis: Causative organisms and visual outcome

European Journal of Ophthalmology

Volumn 9, Issue 1, 1999, Pages 21-31

  Abu El Asrar, Ahmed M ^a,b   Al Amro, S A ^a   Al Mosallam, A A ^a   Al Obeidan, S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Clostridium perfringens; Endophthalmitis; Intraocular foreign body; Penetrating ocular trauma; Staphylococcus epidermidis

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; GENTAMICIN; PREDNISONE; TRIAMCINOLONE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS NIGER; CLINICAL ARTICLE; CLOSTRIDIUM PERFRINGENS; ENDOPHTHALMITIS; ENUCLEATION; EVISCERATION; EYE INJURY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR FOREIGN BODY; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; MALE; PENETRATING TRAUMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; STAPHYLOCOCCUS EPIDERMIDIS; VISUAL ACUITY; VITRECTOMY;

EID: 0345471495     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219900900104     Document Type: Article

References (37)

1. Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology 1980; 87: 313-9.
2. Peyman GA, Raichand M, Bennett TO. Management of endophthalmitis with pars plana vitrectomy. Br J Ophthalmol 1980; 64: 472-5.
3. Rowsey JJ, Newsom DL, Sexton DJ, Harms WK. Endophthalmitis: Current approaches. Ophthalmology 1982; 89: 1055-66.
4. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Ophthalmology 1982; 89: 921-9.
5. Brinton GS, Topping TM, Hyndiuk RA, Aaberg TM, Reeser FH, Abrams GW. Posttraumatic endophthalmitis. Arch Ophthalmol 1984; 102: 547-50.
6. Affeldt JC, Flynn HW Jr, Forster RK, Mandelbaum S, Clarkson JG, Jarus GD. Microbial endophthalmitis resulting from ocular trauma. Ophthalmology 1987; 94: 407-13.
7. Alfaro DV, Roth D, Liggett PE. Posttraumatic endophthalmitis. Causative organisms, treatment, and prevention. Retina 1994; 14: 206-11.
8. Verbraken H, Rysselaere M. Post-traumatic endophthalmitis. Eur J Ophthalmol 1994; 4: 1-5.
9. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996; 122: 1-7.
10. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA, for the Endophthalmitis Vitrectomy Study Group. The source of coagulase-negative Staphylococci in the endophthalmitis vitrectomy study. A comparison of eyelid and intraocular osilates using pulsed-field gel electrophoresis. Arch Ophthalmol 1997; 115: 357-61.
11. Peters G, Pulverer G. Pathogenesis and management of Staphylococcus epidermidis "plastic" foreign body infections. J Antimicrob Chemother 1984; 14 (Suppl): S67-71.
12. Vahey JB, Flynn HW Jr. Results in the management Bacillus endophthalmitis. Ophthalmic Surg 1991; 22: 681-6.
13. Boldt HC, Pulido JS, Blodi CF, Folk JC, Weingeist TA. Rural endophthalmitis. Ophthalmology 1989; 96: 1722-6.
14. Munakata N, Saitou M, Takahashi N, Hieda K, Morohoshi F. Induction of unique tandem-base change mutations in bacterial spores exposed to extreme dryness. Mutat Res 1997; 390: 189-95.
15. Xue Y, Nicholson WL. The two major spore DNA repair pathways, nucleotide excision repair and spore photo product lyase, are sufficient for the resistance of Bacillus subtitlis to artificial UV-C and UV-B but not to solar radiation. Appl Environ Microbiol 1996; 62: 2221-7.
16. Leavelle RB. Gas gangrene panophthalmitis. Review of the literature; report of new cases. Arch Ophthalmol 1955; 53: 634-42.
17. Duke-Elder S, Perkins ES. Gas gangrene panophthalmitis. In: System of ophthalmology, Vol 9. St. Louis: Mosby, 1966: 242-4.
18. Frantz JF, Lemp MA, Font RL, Stone R, Eisner E. Acute endogenous panophthalmitis caused by Clostridium perfringens. Am J Ophthalmol 1974; 78: 295-303.
19. Crock GW, Heriot WJ, Janakiraman P, Weiner JM. Gas gangrene infection of the eyes and orbits. Br J Ophthalmol 1985; 69: 143-8.
20. Olk RJ, Bohigan GM. The management of endophthalmitis: diagnostic and therapeutic guidelines including the use of vitrectomy. Ophthalmic Surg 1987; 18: 262-6.
21. Diamond JG. Intraocular management of endophthalmitis. A systematic approach. Arch Ophthalmol 1981; 99: 96-9.
22. Mandelbaum S, Forster RK. Postoperative endophthalmitis. Int Ophthalmol Clin 1987; 27: 95-106.
23. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113:1479-96.
24. Flynn HW Jr, Brod RD, Pflugfelder SC, Miller D. Endophthalmitis management. In: Tasman W, Jaeger EA, eds. Duane's clinical ophthalmology. Vol. 6, Philadelphia: J.B. Lippincott Company, 1994; 1-22; Chap 64.
25. Barr CC. Prognostic factors in corneoscleral lacerations. Arch Ophthalmol 1983; 101: 919-24.
26. Thompson JT, Parver LM, Enger CL, Mieler WF, Liggett PE. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. Ophthalmology 1993; 100: 1468-74.
27. Ariyasu RG, Kumar S, La Bree LD, Wagner DG, Smith RE. Microorganisms cultured from the anterior chamber of ruptured globes at the time of repair. Am J Ophthalmol 1995; 119: 181-8.
28. Meredith TA. Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime. Trans Am Ophthalmol Soc 1993; 91: 653-99.
29. Meredith TA, Aguilar HE, Shaarawy A, Kincaid M, Dick J, Niesman MR. Vancomycin levels in the vitreous cavity after intravenous administration. Am J Ophthalmol 1995; 119: 774-8.
30. Yoshizumi MO, Leinwand MJ, Kim J. Topical and intravenous gentamicin in traumatically lacerated eyes. Graefe's Arch Clin Exp Ophthalmol 1992; 230: 175-7.
31. El-Massry A, Meredith TA, Aguilar HE, et al. Aminoglycoside levels in the rabbit vitreous cavity after intravenous administration. Am J Ophthalmol 1996; 122: 684-9.
32. Mieler WF, Ellis MK, Williams DF, Han DP. Retained intraocular foreign bodies and endophthalmitis. Ophthalmology 1990; 97: 1532-8.
33. Speaker MG, Menikoff JA. Postoperative endophthalmitis: pathogenesis, prophylaxis, and management. Int Ophthalmol Clin 1993; 33: 51-69.
34. Davis JL, Koidou-Tsiligianni A, Pflugfelder SC, Miller D, Flynn HW Jr, Forster RK. Coagulase-negative staphylococci endophthalmitis. Increase in antimicrobial resistance. Ophthalmology 1988; 95: 1404-10.
35. Ormered LD, Ho DD, Becker LE, et al. Endophthalmitis caused by the coagulase negative Staphylococci-I. Disease spectrum and outcome. Ophthalmology 1993; 100: 715-23.
36. Campochiaro PA, Conway BP. Aminoglycoside toxicity: a survey of retinal specialists: implication for ocular use. Arch Ophthalmol 1991; 109: 946-50.
37. Campochiaro PA, Lim JI, the aminoglycoside toxicity study group. Aminoglycoside toxicity in the treatment of endophthalmitis. Arch Ophthalmol 1994; 112:48-53.